Unified implementation and comparison of Bayesian shrinkage methods for treatment effect estimation in subgroups
亚组治疗效应的贝叶斯收缩方法:统一实现与比较
Evaluating treatment effect heterogeneity across patient subgroups is a fundamental aspect of clinical trial analysis. These analyses have inherent limitations due to small sample sizes and the substantial number of subgroups investigated. There is a tendency to focus on extreme estimates, which may reflect random variation rather than true effects, potentially leading to spurious clinical conclusions. Statisticians in regulatory agencies and pharmaceutical companies have…